Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Mimetix, NanoSystems to collaborate on novel naproxen formulation

May 10, 1996

TAK-218 discussed at length at Japanese meetings

May 3, 1996

Tanabe's T-477 shows neuroprotective effects

May 3, 1996

Jouveinal's neuroprotective sigma ligand JO-1994

May 3, 1996

RPR describes NMDA/glycine-site antagonists

May 3, 1996

Maxi-K channel modulators from Bayer

May 3, 1996

Berlex attempts to block approval of Avonex in U.S.

May 3, 1996

Pola describes dopamine reuptake inhibitors for Parkinson's disease

May 3, 1996

Astrotactin-producing gene may aid in understanding of epilepsy

May 3, 1996

Novel sertraline composition for mood disorders

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...